
Apago PDF Enhancer
1068
part
VII
Animal Form and Function
Because cytokines are quite potent, they are generally se-
creted at very low concentrations so that, with a few exceptions,
they bind only to nearby cells. IL-1 is an exception in that it
travels to the hypothalamus to induce the fever response. Dif-
ferent subsets of T
H
cells secrete cytokines specific for different
cell receptors, so it is largely the T
H
cells and the cytokines they
secrete that determine whether an immune response will be
humoral or cell-mediated in nature.
T
H
cells respond to exogenous antigen that has been
brought into an antigen-presenting cell. Macrophages or
dendritic cells acquire these antigens by phagocytosis or en-
docytosis, and B cells gain them through receptor-mediated
endocytosis. Once inside these cells, the antigen is gradually
degraded in increasingly acidic endosomes or lysosomes. Pep-
tides of the antigen join with MHC class II proteins in certain
of these endosomes, and the MHC class II–peptide complexes
are then transported to and displayed on the cell surface of the
antigen-presenting cell. T
H
cells encounter these cells within
the secondary lymphoid organs and bind to the complexes.
The CD4 protein of the T
H
cells additionally bind to con-
served regions of MHC class II.
A naive T
H
cell expresses a protein called CD28 that must
bind to a protein called B7 if that T cell is to be activated. B7 is
found only on antigen-presenting cells and is at highest levels
on dendritic cells. This requirement ensures that T
H
cells are
activated only when needed; this careful regulation is necessary
due to the potency of the cytokines these cells release.
As with T
C
cells, an activated T
H
cell gives rise to a
clone of T
H
cells including both effector T
H
cells and mem-
ory T
H
cells, with identical TCR specificity. Most of the
effector cells will leave the lymphoid organ and circulate
around the body.
T cells are the primary cells that
mediate transplant rejection
When T cells encounter the nonself MHC–peptide complexes
present on transplanted tissue, such as a kidney, the TCRs on
many of the T cells can weakly bind to these complexes. This
is simply a case of cross-reactivity: The structure of a nonself
MHC–peptide complex sufficiently resembles that of the self-
MHC–foreign-peptide complex. The result is that the T cell
binds to the foreign tissue cell.
Although the interactions between TCRs and nonself
MHC–peptide complexes are relatively weak, many interac-
tions occur between any one T cell and any one transplanted
cell because a high density of MHC proteins is present on the
surface of all cells. This activates the T cells and initiates the
attack on the foreign tissues.
Because of the genetic basis of MHC proteins, the
more closely two individuals are related, the less their MHC
proteins vary, and thus the more likely they will be to toler-
ate each other’s tissues. As a result, relatives are often sought
as donors for patients in need of an organ transplant, and
HLA typing is done to find matching alleles.
A variety of drugs are used to suppress immune system
rejection of a transplant; most individuals with a non-MHC-
matched transplant continue to take some of these drugs for the
remainder of their lives. One very effective drug is cyclosporin,
which blocks the activation of lymphocytes.
Cells of the innate immune
system release cytokines
Many cells in addition to T
H
cells release cytokines, always in a
carefully regulated fashion. For example, macrophages that have
been activated by phagocytosis of antigen, or by the binding of
PAMP molecules to TLRs on their surface, release cytokines
such as interleukin-12 (IL-12) that can, in turn, bind to T
H
cells
to increase their level of activation. Macrophages with TLRs
bound to PAMP also release other cytokines, such as tumor ne-
crosis factor-α (TNF-α). These cytokines bind to blood vessels
to induce a local or even systemic increase in vascular permeabil-
ity. This links the innate response to the adaptive response.
Learning Outcomes Review 52.3
T cells respond to peptides of foreign antigens displayed on self-MHC
proteins. Activated T
C
cells induce apoptosis of altered self cells—those that
are virally infected or are tumor cells. T
H
cells secrete cytokines that promote
either cell-mediated or humoral immune responses.
■ How are T-cell receptors different from Toll-
like receptors?
52.4
Humoral Immunity
and Antibody Production
Learning Outcomes
Explain how antibody diversity is generated.1.
List the five classes of immunoglobulins.2.
Explain how vaccination prevents disease.3.
The B-cell receptors for antigen are the immunoglobulin mol-
ecules present as integral proteins in the plasma membrane. As
noted earlier, each B cell exhibits about 10
5
immunoglobulin
molecules of identical specificity for a particular epitope of an
antigen. Naive B cells in secondary lymph organs encounter
antigens. When immunoglobulin molecules on a B cell bind
to a specific epitope on an antigen, and the B cell receives ad-
ditional required signals, particularly cytokines secreted by
T
H
cells, then that B cell becomes activated, proliferating into
plasma cells and memory cells (figure 52.13) .
Each plasma B cell is a miniature factory producing solu-
ble antibodies of the same specificity as the membrane-bound
antibodies of the parent B cell. These antibodies enter the
lymph and blood circulation as well as the extracellular fluid,
and they bind to the appropriate epitopes of antigen encoun-
tered anywhere in the body. Any one antigen may present a
variety of epitopes, so that different B cells might recognize
different epitopes of a single antigen.
rav32223_ch52_1055-1083.indd 1068rav32223_ch52_1055-1083.indd 1068 11/19/09 1:45:25 PM11/19/09 1:45:25 PM